Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
intermediate endpoints
Description:
Clinical trial outcomes measured before final health outcomes, often used to assess treatment effects or as surrogate measures.
Related topics:
Statistical Methods in Clinical Trials (19%),
Prostate Cancer Treatment and Research (7%)
OpenAlex ID:
keywords/intermediate-endpoints
Common Carotid Intima-Media Thickness and Risk of Stroke and Myocardial Infarction: The Rotterdam Study
1997
·
Michiel L. Bots
, Arno W. Hoes
, et al.
·
Circulation
·
2,607
Design of the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial
2000
·
Philip C. Prorok
, Gerald L. Andriole
, et al.
·
Controlled Clinical Trials
·
1,107
Statistical validation of intermediate endpoints for chronic diseases
1992
·
Laurence S. Freedman
, Barry I. Graubard
, et al.
·
Statistics in Medicine
·
716
Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data
2009
·
Howard I Scher
, Xiaoyu Jia
, et al.
·
The Lancet Oncology
·
656
Design Issues of Randomized Phase II Trials and a Proposal for Phase II Screening Trials
2005
·
Lawrence V. Rubinstein
, Edward L. Korn
, et al.
·
Journal of Clinical Oncology
·
429
A panel of biomarkers of carcinogenesis of the upper aerodigestive tract as potential intermediate endpoints in chemoprevention trials
1993
·
Marcel P. Copper
, Boudewijn J. M. Braakhuis
, et al.
·
Cancer
·
370
Insulin-like growth factor physiology and cancer risk
2000
·
M Pollak
·
European Journal of Cancer
·
308
Sample Size for Studying Intermediate Endpoints within Intervention Trials or Observational Studies
1992
·
Laurence S. Freedman
, Arthur Schatzkin
·
American Journal of Epidemiology
·
270
Circulating tumour cell (CTC) counts as intermediate end points in castration-resistant prostate cancer (CRPC): a single-centre experience
2008
·
D. Olmos
, H.-T. Arkenau
, et al.
·
Annals of Oncology
·
265
PDF
Validation of Intermediate End Points in Cancer Research
1990
·
Arthur Schatzkin
, Laurence S. Freedman
, et al.
·
JNCI Journal of the National Cancer Institute
·
241
Randomized placebo-controlled trial of isotretinoin in chemoprevention of bronchial squamous metaplasia.
1994
·
J S Lee
, S M Lippman
, et al.
·
Journal of Clinical Oncology
·
224
Monitoring Osteoporosis Therapy: Bone Mineral Density, Bone Turnover Markers, or Both?
2006
·
Sydney Lou Bonnick
, Lee Shulman
·
The American Journal of Medicine
·
222
PDF
Biomarkers as Intermediate End Points in Chemoprevention Trials
1990
·
S. M. Lippman
, J. S. Lee
, et al.
·
JNCI Journal of the National Cancer Institute
·
197
Artificial Intelligence Predictive Model for Hormone Therapy Use in Prostate Cancer
2023
·
Daniel E. Spratt
, Siyi Tang
, et al.
·
NEJM Evidence
·
178
PDF
Time to Review the Role of Surrogate End Points in Health Policy: State of the Art and the Way Forward
2016
·
Oriana Ciani
, Marc Buyse
, et al.
·
Value in Health
·
175
Surrogate endpoints: A basis for a rational approach
1992
·
J. -P. Boissel
, J. -P. Collet
, et al.
·
European Journal of Clinical Pharmacology
·
175
Overall Survival As the Outcome for Randomized Clinical Trials With Effective Subsequent Therapies
2011
·
Edward L. Korn
, Boris Freidlin
, et al.
·
Journal of Clinical Oncology
·
152
Regression Modeling of Semicompeting Risks Data
2006
·
Limin Peng
, Jason P. Fine
·
Biometrics
·
147
Radiographic Progression-Free Survival As a Response Biomarker in Metastatic Castration-Resistant Prostate Cancer: COU-AA-302 Results
2015
·
Michael J. Morris
, Arturo Molina
, et al.
·
Journal of Clinical Oncology
·
145
Establishing the Cost-Effectiveness of New Pharmaceuticals under Conditions of Uncertainty—When Is There Sufficient Evidence?
2005
·
Mark Sculpher
, Karl Claxton
·
Value in Health
·
143
Definitions and validation criteria for biomarkers and surrogate endpoints: development and testing of a quantitative hierarchical levels of evidence schema.
2007
·
Marissa N Lassere
, Kent R Johnson
, et al.
·
PubMed
·
141
Real‐world progression, treatment, and survival outcomes during rapid adoption of immunotherapy for advanced non–small cell lung cancer
2019
·
Sean Khozin
, Rebecca A. Miksad
, et al.
·
Cancer
·
139
PDF
The Noninvasive Assessment of Vascular Aging
2016
·
Stéphane Laurent
, Louise Marais
, et al.
·
Canadian Journal of Cardiology
·
129
Time to Prostate Specific Antigen Recurrence After Radical Prostatectomy and Risk of Prostate Cancer Specific Mortality
2006
·
Stephen J. Freedland
, Elizabeth B. Humphreys
, et al.
·
The Journal of Urology
·
126
Noninvasive Detection of Subclinical Coronary Atherosclerosis Coupled With Assessment of Changes in Plaque Characteristics Using Novel Invasive Imaging Modalities
2006
·
Carlos A.G. Van Mieghem
, Eugène P. McFadden
, et al.
·
Journal of the American College of Cardiology
·
121
PDF
Show more works
View as search
Works count:
505
Citation count:
16,040
Year
Topic
Type